Revision history of "Synthesis and development of new Sigma-1 receptor positive alosthering modulators for Alzheimer’s therapy." (Q3056336)

12 March 2024

• curprev 14:1714:17, 12 March 2024‎ DG Regio talk contribs‎ 87,747 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.1393672150925498

12 June 2023

• curprev 09:0809:08, 12 June 2023‎ Admin talk contribs‎ 87,459 bytes +437‎ BatchIngestion

3 August 2022

• curprev 20:0420:04, 3 August 2022‎ DG Regio talk contribs‎ 87,022 bytes +57,109‎ ‎Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, lv, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, ga, sl, bg, mt, pt, da, ro, sv,

12 January 2022

• curprev 17:3717:37, 12 January 2022‎ DG Regio talk contribs‎ 29,913 bytes +3,288‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

11 January 2022

• curprev 10:0810:08, 11 January 2022‎ DG Regio talk contribs‎ 26,625 bytes +3,242‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

28 November 2021

• curprev 18:0118:01, 28 November 2021‎ DG Regio talk contribs‎ 23,383 bytes +3,173‎ ‎Created claim: summary (P836): 1.1.1.Beknopte beschrijving van de samenvatting van het project (de verstrekte informatie mag niet meer dan 200 woorden bedragen, evenals drie tot zeven geplande sleutelwoorden die het project beschrijven) De ziekte van Alcheimer (AD) is de meest voorkomende dementie in verband met leeftijd. Ligands met een hoge affiniteit voor de Sigma-1-receptor (Sig1R) worden beschouwd als een belangrijke rol bij de behandeling van verschillende neurologische...
• curprev 18:0118:01, 28 November 2021‎ DG Regio talk contribs‎ 20,210 bytes +183‎ ‎Changed label, description and/or aliases in nl: translated_label
• curprev 09:2609:26, 28 November 2021‎ DG Regio talk contribs‎ 20,027 bytes +3,051‎ ‎Created claim: summary (P836): 1.1.1.Kurzbeschreibung der Projektzusammenfassung (die bereitgestellten Informationen dürfen 200 Wörter nicht überschreiten, sowie drei bis sieben geplante Schlüsselwörter, die das Projekt beschreiben)Alcheimer-Krankheit (AD) ist die häufigste Demenz im Zusammenhang mit dem Alter. Liganden mit hoher Affinität für den Sigma-1-Rezeptor (Sig1R) spielen eine wichtige Rolle bei der Behandlung verschiedener neurologischer Erkrankungen, darunter Alzhei...
• curprev 09:2609:26, 28 November 2021‎ DG Regio talk contribs‎ 16,976 bytes +172‎ ‎Changed label, description and/or aliases in de: translated_label

25 November 2021

• curprev 19:3319:33, 25 November 2021‎ DG Regio talk contribs‎ 16,804 bytes +3,198‎ ‎Created claim: summary (P836): 1.1.1.Description sommaire du projet (l’information fournie ne peut dépasser 200 mots, ainsi que trois à sept mots clés planifiés décrivant le projet) La maladie d’Alcheimer (AD) est la démence la plus courante associée à l’âge. Les ligands à forte affinité pour le récepteur Sigma-1 (Sig1R) sont considérés comme jouant un rôle important dans le traitement de divers troubles neurologiques, y compris la maladie d’Alzheimer, la dépression et la dou...
• curprev 19:3319:33, 25 November 2021‎ DG Regio talk contribs‎ 13,606 bytes +207‎ ‎Changed label, description and/or aliases in fr: translated_label

27 September 2021

• curprev 11:5111:51, 27 September 2021‎ DG Regio talk contribs‎ 13,399 bytes +420‎ ‎Changed an Item: modifying co-finance rate with the percentage
• curprev 11:5111:51, 27 September 2021‎ DG Regio talk contribs‎ 12,979 bytes −420‎ ‎Removed claim: co-financing rate (P837): 0.85 percent

10 September 2021

• curprev 14:0114:01, 10 September 2021‎ DG Regio talk contribs‎ 13,399 bytes +420‎ ‎Changed an Item

15 July 2021

• curprev 12:3312:33, 15 July 2021‎ DG Regio talk contribs‎ 12,979 bytes +168‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 12:3312:33, 15 July 2021‎ DG Regio talk contribs‎ 12,811 bytes +2,814‎ ‎Created claim: summary (P836): 1.1.1.A brief description of the summary of the project (not to exceed 200 words and three to seven keywords describing the planned project) Alzheimer’s disease (AD) is the most common dementia associated with age. Ligands with high affinity for the Sigma-1 receptor (Sig1R) are believed to play an important role in the treatment of various neurological disorders including Alzheimer’s disease, depression and neuropathic pain. Our previous LOSIs s...

14 July 2021

• curprev 07:0307:03, 14 July 2021‎ DG Regio talk contribs‎ 9,997 bytes +431‎ ‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string

13 July 2021

• curprev 15:4415:44, 13 July 2021‎ DG Regio talk contribs‎ 9,566 bytes +423‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates
• curprev 10:4010:40, 13 July 2021‎ DG Regio talk contribs‎ 9,143 bytes +505‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location
• curprev 09:5909:59, 13 July 2021‎ DG Regio talk contribs‎ 8,638 bytes +7,868‎ ‎Changed an Item: import item from Latvia
• curprev 09:5909:59, 13 July 2021‎ DG Regio talk contribs‎ 770 bytes −7,868‎ ‎Removed claims Tag: Replaced
• curprev 09:1609:16, 13 July 2021‎ DG Regio talk contribs‎ 8,638 bytes +7,868‎ ‎Changed an Item: import item from Latvia
• curprev 09:1609:16, 13 July 2021‎ DG Regio talk contribs‎ 770 bytes −7,868‎ ‎Removed claims Tag: Replaced
• curprev 09:0909:09, 13 July 2021‎ DG Regio talk contribs‎ 8,638 bytes +4‎ ‎Changed label, description and/or aliases in en: Setting new description
• curprev 09:0909:09, 13 July 2021‎ DG Regio talk contribs‎ 8,634 bytes +8,634‎ ‎Created a new Item: import item from Latvia